Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04367467 · ClinicalTrials.gov registry record
Effect of PARP Inhibitors on Glomerular Filtration Rate
A clinical trial, sponsored by University of Pennsylvania.
- Terminated
- Registry status
- 2
- Enrollment target
NCT04367467: Clinical Trial study, sponsored by University of Pennsylvania.
NCT04367467 is a clinical trial that was terminated before completion, run by University of Pennsylvania. The registered enrollment target is 2 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04367467 was terminated before completion, sponsored by University of Pennsylvania.
- TERMINATED
- Registry status
- 2 participants
- Enrollment target
Study Summary
The purpose of this study is to observe whether PARP inhibitors have an effect on serum creatinine level, and whether this reflects a change in creatinine secretion or a true change in kidney function.
Interventions
- OTHER Kidney Function Test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2020-02-03 |
| Est. Completion | 2021-07-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04367467
The ClinicalTrials.gov registry entry for NCT04367467 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Kidney Function Test is the first listed.
NCT04367467 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04367467 about?
NCT04367467 is a clinical study titled "Effect of PARP Inhibitors on Glomerular Filtration Rate". The purpose of this study is to observe whether PARP inhibitors have an effect on serum creatinine level, and whether this reflects a change in creatinine secretion or a true change in kidney function.
What is the current status of trial NCT04367467?
This trial is currently terminated. The enrollment target is 2 participants. The study started on 2020-02-03. Estimated completion is 2021-07-01.
What interventions are being tested in trial NCT04367467?
The interventions under investigation include: Kidney Function Test (OTHER).
Who is sponsoring clinical trial NCT04367467?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.